Current remedies for vitiligo
- PMID: 20149899
- DOI: 10.1016/j.autrev.2010.02.013
Current remedies for vitiligo
Abstract
Vitiligo is a disorder with complex causes and is a type of autoimmune disease in which the immune system targets the body's own pigment cells and tissues. Our aim is to present an overall view of the current remedies widely adopted for the treatment of vitiligo. Medical treatments target the immune system, and try to reverse the destruction. The goal is to restore the skin's color by restoring healthy melanocytes to the affected area. Apart from melanocytes, vitiligo autoantigens appear also on other cells. Even though antibodies to pigment cells are not an agent of vitiligo, the most valuable contribution is that anti-melanocyte antibody reactivity can help in identifying relevant antigens. T cells from vitiligo skin are highly reactive towards melanoma cells and serve as an effective source to treat melanoma and stays as a solution for vitiligo. There have been many treatments to cure vitiligo such as use of steroid creams, PUVA (psoralen and ultraviolet A light), narrow band UVB (ultraviolet B), various surgical techniques, vitamin D analogues and pseudocatalase. These treatments are subjected for undesired side effects whereas some herbal and natural treatments act against the immune system with no side effects.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.Autoimmun Rev. 2007 Jan;6(3):138-42. doi: 10.1016/j.autrev.2006.09.010. Epub 2006 Oct 2. Autoimmun Rev. 2007. PMID: 17289548 Review.
-
Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?Ann N Y Acad Sci. 2007 Sep;1110:410-25. doi: 10.1196/annals.1423.043. Ann N Y Acad Sci. 2007. PMID: 17911456 Review.
-
Autoimmunity as an aetiological factor in vitiligo.J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76. doi: 10.1111/j.1468-3083.2007.02228.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17658994 Review.
-
Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).Hum Antibodies Hybridomas. 1996;7(4):151-6. Hum Antibodies Hybridomas. 1996. PMID: 9140726
-
Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.Br J Dermatol. 2007 Jan;156(1):122-9. doi: 10.1111/j.1365-2133.2006.07584.x. Br J Dermatol. 2007. PMID: 17199578
Cited by
-
New perspectives on the role of vitiligo in immune responses to melanoma.Oncotarget. 2011 Sep;2(9):684-94. doi: 10.18632/oncotarget.323. Oncotarget. 2011. PMID: 21911918 Free PMC article. Review.
-
Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.Int J Biol Sci. 2017 Feb 25;13(3):391-400. doi: 10.7150/ijbs.17318. eCollection 2017. Int J Biol Sci. 2017. PMID: 28367103 Free PMC article.
-
Target area treatment ratio of varied lesions in the cultured pure melanocyte transplantation repigmentation of vitiligo: A retrospective study.J Dermatol. 2024 Aug;51(8):1060-1067. doi: 10.1111/1346-8138.17320. Epub 2024 Jun 19. J Dermatol. 2024. PMID: 38895831 Free PMC article.
-
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Pigment Cell Melanoma Res. 2014 Nov;27(6):1075-85. doi: 10.1111/pcmr.12284. Epub 2014 Jul 21. Pigment Cell Melanoma Res. 2014. PMID: 24935676 Free PMC article.
-
The genomic landscapes of individual melanocytes from human skin.Nature. 2020 Oct;586(7830):600-605. doi: 10.1038/s41586-020-2785-8. Epub 2020 Oct 7. Nature. 2020. PMID: 33029006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical